Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Helminthostachys zeylanica extract is a botanical preparation derived from the traditional Chinese medicinal plant *Helminthostachys zeylanica* (L.) Hook, commonly known as 'Dao-Di-U-Gon' in Taiwan. It is being investigated by Changhua Christian Hospital for its potential to enhance functional recovery in patients following surgical intervention for ankle fractures. The extract contains bioactive flavonoids known as ugonins, which possess anti-inflammatory, anti-edema, and analgesic properties. Research indicates that ugonins may facilitate bone healing by promoting osteoblastic differentiation. In clinical trials, the extract is administered orally to reduce post-operative pain and swelling, and to improve wound healing and overall functional outcomes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Helminthostachys zeylanica extract.